MaaT: €13 Million PIPE Deal Closure
Deal News | Apr 03, 2025 | Goodwin
MaaT Pharma, a leading clinical-stage company focusing on innovative microbiome therapies, successfully carried out a private investment in public equity (PIPE) transaction, raising €13 million. The funds will be directed towards achieving significant value milestones, such as navigating market submissions for EU approval of its MaaT013 product. Legal assistance for the transaction was provided by Goodwin, advising investment banks Van Lanschot Kempen N.V., Chardan, and KBC Securities, with the deal steered by a team led by Guilhem Richard and Edwin O'Connor for French and US law aspects respectively.
Sectors
- Biotechnology
- Capital Markets
- Legal Services
Geography
- France – MaaT Pharma is a French company, making France a primary geographic focus of the article.
- European Union – The raised funds are to support EU approval for MaaT013, indicating the significance of the EU in the company's strategy.
- United States – US law aspects were handled by Goodwin, highlighting the US's involvement in the legal advising process.
Industry
- Biotechnology – MaaT Pharma is involved in developing gut microbiome therapies, a key focus area in the biotechnology sector.
- Capital Markets – The article discusses a PIPE transaction, which is a capital markets activity involving private placement of equity.
- Legal Services – Goodwin, a legal advisory firm, played a pivotal role in advising on the legal aspects of the transaction.
Financials
- €13 million – Total amount raised in the PIPE deal for MaaT Pharma.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| MaaT Pharma | Target | Company | A clinical-stage company focused on gut microbiome-driven therapies to improve cancer patient outcomes. |
| Van Lanschot Kempen N.V. | Bidding Companybuyer | Company | A bank involved in the PIPE transaction of MaaT Pharma. |
| Chardan | Bidding Companybuyer | Company | An investment bank advising on MaaT Pharma's capital increase. |
| KBC Securities | Bidding Companybuyer | Company | A financial institution, part of the advising team for MaaT Pharma's equity raise. |
| Goodwin | Legal Advisor | Company | Legal firm advising on both French and US law aspects of the PIPE deal. |
| Guilhem Richard | Legal Advisor | People | Led the Goodwin team on French law aspects of the deal. |
| Edwin O'Connor | Legal Advisor | People | Led the Goodwin team on US law aspects of the deal. |
| Marilna Gryparis | Legal Advisor | People | Part of the Goodwin legal team advising on the deal. |
| Shanna Kim | Legal Advisor | People | Part of the Goodwin legal team advising on the deal. |